首页> 外文期刊>Journal of Extracellular Vesicles >Identification and characterization of EGF receptor in individual exosomes by fluorescence-activated vesicle sorting
【24h】

Identification and characterization of EGF receptor in individual exosomes by fluorescence-activated vesicle sorting

机译:通过荧光激活的囊泡分选鉴定和鉴定单个外来体中的EGF受体

获取原文
           

摘要

Exosomes are small, 40–130 nm secreted extracellular vesicles that recently have become the subject of intense focus as agents of intercellular communication, disease biomarkers and potential vehicles for drug delivery. It is currently unknown whether a cell produces different populations of exosomes with distinct cargo and separable functions. To address this question, high-resolution methods are needed. Using a commercial flow cytometer and directly labelled fluorescent antibodies, we show the feasibility of using fluorescence-activated vesicle sorting ( FAVS) to analyse and sort individual exosomes isolated by sequential ultracentrifugation from the conditioned medium of DiFi cells, a human colorectal cancer cell line. EGFR and the exosomal marker, CD9, were detected on individual DiFi exosomes by FAVS; moreover, both markers were identified by high-resolution stochastic optical reconstruction microscopy on individual, approximately 100 nm vesicles from flow-sorted EGFR/CD9 double-positive exosomes. We present evidence that the activation state of EGFR can be assessed in DiFi-derived exosomes using a monoclonal antibody (mAb) that recognizes “conformationally active” EGFR (mAb 806). Using human antigen-specific antibodies, FAVS was able to detect human EGFR and CD9 on exosomes isolated from the plasma of athymic nude mice bearing DiFi tumour xenografts. Multicolour FAVS was used to simultaneously identify CD9, EGFR and an EGFR ligand, amphiregulin (AREG), on human plasma-derived exosomes from 3 normal individuals. These studies demonstrate the feasibility of FAVS to both analyse and sort individual exosomes based on specific cell-surface markers. We propose that FAVS may be a useful tool to monitor EGFR and AREG in circulating exosomes from individuals with colorectal cancer and possibly other solid tumours.
机译:外泌体是小的,分泌40-130 nm的细胞外囊泡,最近已成为细胞间通讯,疾病生物标志物和潜在药物传递媒介的焦点。目前尚不清楚细胞是否产生具有不同货物和可分离功能的不同外泌体群体。为了解决这个问题,需要高分辨率的方法。使用商业流式细胞仪和直接标记的荧光抗体,我们展示了使用荧光激活的囊泡分选(FAVS)分析和分选通过顺序超速离心从人结肠直肠癌细胞系DiFi细胞的条件培养基中分离的单个外泌体的可行性。通过FAVS在单个DiFi外泌体上检测到EGFR和外泌体标记CD9。此外,通过高分辨率随机光学重建显微镜在流分类的EGFR / CD9双阳性外泌体的单个约100 nm囊泡上鉴定了这两种标记。我们提供的证据表明,可以使用识别“构象活性” EGFR(mAb 806)的单克隆抗体(mAb)在DiFi衍生的外来体中评估EGFR的激活状态。使用人类抗原特异性抗体,FAVS能够在分离自携带DiFi肿瘤异种移植的无胸腺裸小鼠血浆的外泌体中检测人EGFR和CD9。多色FAVS用于同时鉴定3个正常个体的人血浆来源外泌体上的CD9,EGFR和EGFR配体双调蛋白(AREG)。这些研究证明了FAVS根据特定的细胞表面标志物分析和分类单个外泌体的可行性。我们建议FAVS可能是监测结直肠癌和其他可能的实体瘤患者循环外泌体中EGFR和AREG的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号